Journal of Diabetes and Its Complications
Volume 21, Issue 3 , Pages 187-195 , May 2007

Effects of fidarestat, an aldose reductase inhibitor, on nerve conduction velocity and bladder function in streptozotocin-treated female rats

  • Elena G. Zotova

      Affiliations

    • Department of Neurology, Albert Einstein College of Medicine, Yeshiva University, Bronx, NY 10461, USA
    • ,
  • George J. Christ

      Affiliations

    • Wake Forest Institute for Regenerative Medicine, Wake Forest University School of Medicine, Winston-Salem, NC, USA
    • Department of Urology, Wake Forest University School of Medicine, Winston-Salem, NC, USA
    • Department of Physiology and Pharmacology, Wake Forest University School of Medicine, Winston-Salem, NC, USA
    • ,
  • Weixin Zhao

      Affiliations

    • Wake Forest Institute for Regenerative Medicine, Wake Forest University School of Medicine, Winston-Salem, NC, USA
    • Department of Urology, Wake Forest University School of Medicine, Winston-Salem, NC, USA
    • ,
  • Moses Tar

      Affiliations

    • Department of Urology, Albert Einstein College of Medicine, Yeshiva University, Bronx, NY 10461, USA
    • ,
  • Srini D. Kuppam

      Affiliations

    • Department of Urology, Albert Einstein College of Medicine, Yeshiva University, Bronx, NY 10461, USA
    • ,
  • Joseph C. Arezzo

      Affiliations

    • Department of Neuroscience, Albert Einstein College of Medicine, Yeshiva University, Bronx, NY 10461, USA
    • Department of Neurology, Albert Einstein College of Medicine, Yeshiva University, Bronx, NY 10461, USA
    • Corresponding Author InformationCorresponding author. Department of Neuroscience, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, NY 10461, USA. Tel.: +1 718 430 2468; fax: +1 718 430 8588.

Received 20 October 2005 ,Accepted 20 October 2005.

References 

  1. Abbate SL, Atkinson MB, Breuer AC. Amount and speed of fast axonal transport. Diabetes. 1991;40:111–117
  2. Alloussi S, Mast GJ, Kopper B, Ziegler M. Micturition disorder as a sequela of sacral autonomic diabetic neuropathy. Urologe A. 1985;24:291–295
  3. Apfel SC. Neurotrophic factors in the therapy of diabetic neuropathy. European Neurology. 1999;41:27–34
  4. Apfel SC, Arezzo JC, Brownlee M, Federoff H, Kessler JA. Nerve growth factor administration protects against experimental diabetic sensory neuropathy. Brain Research. 1994;634:7–12
  5. Arezzo JC Fidarestat Study Group. Efficacy of fidarestat in a phase II trial: Correlation of improvement in functional measures with baseline HbA1c and induced sorbitol suppression. In: International Polyol Pathway Conference, Hawaii. 2004;
  6. Arezzo JC, Zotova E. Electrophysiologic measures of diabetic neuropathy: Mechanism and meaning. In:  Tomlinson D editors. Neurobiology of diabetic neuropathy. International Review of Neurobiology. Vol. 50:New York: Academic Press; 2002;p. 230–255
  7. Bianchi R, Triban C, Marini P, Figliomeni B, Paro M, Italiano G, et al. Inner ester derivatives of gangliosides protect autonomic nerves of alloxan diabetic rats against Na+,K(+)-ATPase activity defects. Diabetes Research and Clinical Practice. 1991;12:107–111
  8. Boulton AJM, Arezzo JC, Malik RA, Sosenko JM. Diabetic somatic neuropathies. Diabetes Care. 2004;27:1458–1486
  9. Brown J, Posner S, Stewart A. Urge incontinence: New health-related quality of life measures. Journal of the American Geriatrics Society. 1999;47:980–988
  10. Brown J, Seeley D, Fong J, Black D, Ensrud K, Grady D. Urinary incontinence in older women: Who is at risk?. Obstetrics and Gynecology. 1996;87:715–721
  11. Brown JS, Nyberg LM, Kusek JW, Burgio KL, Diokno AC, Foldspang A, et al. National Institute of Diabetes and Digestive Kidney Diseases International Research Working Group on Bladder Dysfunction. Proceedings of the National Institute of Diabetes and Digestive and Kidney Diseases International Symposium on epidemiologic issues in urinary incontinence in women. American Journal of Obstetrics and Gynecology. 2003;188:S77–S88
  12. Brown JS, Subak LL, Gras J, Brown BA, Kuppermann M, Posner SF. Urge incontinence: The patient's perspective. Journal of Women's Health. 1998;7:1263–1269
  13. Brown JS, Wessels H, Chancellor MB, Howards SS, Stamm WE, Stapleton AE, et al. Urologic complications of diabetes. Diabetes Care. 2005;28:177–185
  14. Calcutt NA, Dines KC, Ceseña RM. Effects of the peptide HP228 on nerve disorders in diabetic rats. Metabolism. 1998;47:650–656
  15. Cameron NE, Cotter MA, Jack AM, Basso MD, Hohman TC. Protein kinase C effects on nerve function, perfusion, Na(+),K(+)-ATPase activity and glutathione content in diabetic rats. Diabetologia. 1999;42:1120–1130
  16. Christ GJ, Day NS, Day M, Santizo C, Zhao W, Sclafani T, et al. Bladder injection of “naked” hSlo/pcDNA3 ameliorates detrusor hyperactivity in obstructed rats in vivo. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology. 2001;281:R1699
  17. Christ GJ, Day NS, Day M, Zhao W, Persson K, Pandita RK, et al. Increased connexin43-mediated intercellular communication in a rat model of bladder overactivity in vivo. American Journal of Physiology. Regulatory, Integrative and Comparative physiology. 2003;284:R1241–R1248
  18. Dall'Ago P, Silva VO, DeAngelis KL, Irigoyen MC, Fazan R, Salgado HC. Reflex control of arterial pressure and heart rate in short-term streptozotocin diabetic rats. Brazilian Journal of Medical and Biological Research. 2002;35:843–849
  19. Diokno AC, Brock BM, Herzog AR, Bromberg J. Medical correlates of urinary incontinence in the elderly. Urology. 1990;36:129–138
  20. Djemli-Shipkolye A, Coste T, Raccah D, Vague P, Pieroni G, Gerbe A. Na,K-Atpase alterations in diabetic rats: Relationship with lipid metabolism and nerve physiological parameters. Cellular and Molecular Biology (Noisy-le-Grand, France). 2001;47:297–304
  21. Ellenberg M. Development of urinary bladder dysfunction in diabetes mellitus. Annals of Internal Medicine. 1980;92:321–323
  22. Engelgau MM, Narayan KM, Saaddine JB, Vinicor F. Addressing the burden of diabetes in the 21st century: Better care and primary prevention. Journal of the American Society of Nephrology. 2003;14:S88–S91
  23. Faerman I, Maler M, Jadzinsky M, Alvarez E, Fox D, Zilbervarb J, et al. Asymptomatic neurogenic bladder in juvenile diabetics. Diabetologia. 1971;7:168–172
  24. Frimodt-Moller C. Diabetic cystopathy. A review of the urodynamic and clinical features of neurogenic bladder dysfunction in diabetes mellitus. Danish Medical Bulletin. 1978;25:49–60
  25. Frimodt-Moller C, Mortensen S. Treatment of diabetic cystopathy. Annals Internal Medicine. 1980;92:327–328
  26. Green A, Jaspan J, Kavin H, Chung S, Schoenberg H. Influence of long-term aldose reductase inhibitor therapy on autonomic dysfunction of urinary bladder, stomach and cardiovascular systems in diabetic patients. Diabetes Research and Clinical Practice. 1987;4:67–75
  27. Hellweg R, Hartung HD. Endogenous levels of nerve growth factor (NGF) are altered in experimental diabetes mellitus: A possible role for NGF in the pathogenesis of diabetic neuropathy. Journal of Neuroscience Research. 1990;26:258–267
  28. Hirata Y, Okada K. Relation of Na+,K(+)-ATPase to delayed motor conduction velocity: Effect of aldose reductase inhibitor, AND-138, on Na+,K(+)-ATPase activity. Metabolism. 1990;39:563–567
  29. Hohman TC, Cotter MA, Cameron NE. ATP-sensitive K(+) channel effects on nerve function, Na(+),K(+) ATPase, and glutathione in diabetic rats. European Journal of Pharmacology. 2000;397:335–341
  30. Hotta N, Toyota T, Matsuoka K, Shigeta Y, Kikkawa R, Kaneko T, et al. The SNK-860 Diabetic Neuropathy Study Group. Clinical efficacy of fidarestat, a novel aldose reductase inhibitor, for diabetic peripheral neuropathy: A 52-week multicenter placebo-controlled double-blind parallel group study. Diabetes Care. 2001;24:1776–1782
  31. Jackson RA, Vittinghoff E, Kanaya AM, Miles TP, Resnick HE, Kritchevsky SB, et al. Urinary incontinence in elderly women: Findings from the health, aging, and body composition study. Obstetrics and Gynecology. 2004;104:301–307
  32. Kann O, Schuchmann S, Buchheim K, Heinemann U. Coupling of neuronal activity and mitochondrial metabolism as revealed by NAD(P)H fluorescence signals in organotypic hippocampal slice cultures of the rat. Neuroscience. 2003;119:87–100
  33. Kato N, Mizuno K, Makino M, Nakano K, Suzuki T, Yagihashi S. Effects of 15-month aldose reductase inhibition with fidarestat on the experimental diabetic neuropathy in rats. Diabetes Research and Clinical Practice. 2000;50:77–85
  34. Kato N, Mizuno K, Matsubara A, Nakano K, Kurono M, Yagihashi S. Effect of long-term treatment with new aldose reductase inhibitor, (2S,4S)-6-fluoro-2′,5′-dioxospiro[chroman-4,4′-imidazolidine]-2-carboxamide (SNK-860), on peripheral neuropathy in streptozotocin-induced diabetic rats. Journal of Diabetes and its Complications. 1994;8:27–32
  35. Kato N, Yashima S, Suzuki T, Nakayama Y, Jomori T. Long-term treatment with fidarestat suppresses the development of diabetic retinopathy in STZ-induced diabetic rats. Journal of Diabetes and its Complications. 2003;17:374–379
  36. Lee PG, Hohman TC, Cai F, Regalia J, Helke CJ. Streptozotocin-induced diabetes causes metabolic changes and alterations in neurotrophin content and retrograde transport in cervical vagus nerve. Experimental Neurology. 2001;170:149–161
  37. Marks JB, Raskin P. Cardiovascular risk in diabetes. A brief review. Journal of Diabetes and its Complications. 2000;14:108–115
  38. McVary KT, Rathnau CH, McKenna KE. Sexual dysfunction in the diabetic BB/WOR rat: A role of central neuropathy. American Journal of Physiology. 1997;272:R259–R267
  39. Menendez V, Cofan F, Talbot-Wright R, Ricart J, Gutierrez R, Carretero P. Urodynamic evaluation in simultaneous insulin-dependent diabetes mellitus and end stage renal disease. Journal of Urology. 1996;155:2001–2004
  40. Mitsui T, Kakizaki H, Kobayashi S, Morita H, Matsumura K, Koyanagi T. Vesicourethral function in diabetic patients: Association of abnormal nerve conduction velocity with vesicourethral dysfunction. Neurourology and Urodynamics. 1999;18:639–645
  41. Mizuno K, Kato N, Makino M, Suzuki M, Shindo M. Continuous inhibition of excessive polyol pathway flux in peripheral nerves by aldose reductase inhibitor fidarestat leads to improvement of diabetic neuropathy. Journal of Diabetes and its Complications. 1999;13:141–150
  42. Mizuno K, Kato N, Matsubara A, Nakato K, Kuruno M. Effects of new aldose reductase inhibitor, (2S,4S)-6-fluoro-2′,5′-dioxospiro[chroman-4,4′-imidazolidine]-2-carboxamide (SNK-860), on the slowing of motor nerve conduction velocity and metabolic abnormalities in the peripheral nerve in acute streptozotocin-induced diabetic rats. Metabolism. 1992;41:1081–1086
  43. Nadelhaft I, Vera PL. Reduced urinary bladder afferent conduction velocities in streptozocin diabetic rats. Neuroscience Letters. 1992;135:276–278
  44. Oates PJ. Polyol pathway and diabetic peripheral neuropathy. In:  Tomlinson D editors. International review of neurobiology. Neurobiology of Diabetic Neuropathy. Vol. 50:New York: Academic Press; 2002;p. 326–377
  45. Obrosova IG, Minchenko AG, Vasupuram R, White L, Abaton OI, Kumagai AK, et al. Aldose-reductase inhibitor fidarestat prevents retinal oxidative stress and vascular endothelial growth factor overexpression in streptozotocin-diabetic rats. Diabetes. 2003;53:864–871
  46. Paro M, Italiano G, Travagli RA, Petrelli L, Zanoni R, Prodosdocimi M, et al. Cystometric changes in alloxan diabetic rats: Evidence for functional and structural correlates of diabetic autonomic neuropathy. Journal of the Autonomic Nervous System. 1990;30:1–11
  47. Paro M, Prashar A, Prodosdocimi M, Cherian PV, Fiori MG, Sima AA. Urinary bladder dysfunction in the BB/W diabetic rat: Effect of ganglioside treatment on functional and structural alterations. Journal of Urology. 1994;151:781–786
  48. Salinas CJ, Virseda CM, Adot ZJM, Teba del Pino F, Arredondo MF, Hernandez LA, et al. Diabetic neurocystopathy: Multivariate study. Archivos Espanoles de Urologia. 1999;52:149–156
  49. Sasaki K, Chancellor MB, Goins WF, Phelan MW, Glorioso JC, de Groat WC, et al. Gene therapy using replication-defective herpes simplex virus vectors expressing nerve growth factor in a rat model of diabetic cystopathy. Diabetes. 2004;53:2723–2730
  50. Sasaki K, Yoshimura N, Chancellor MB. Implications of diabetes mellitus in urology. Urologic Clinics of North America. 2003;30(1):1–12
  51. Schmidt RE. Neuropathology and pathogenesis of diabetic autonomic neuropathy. In:  Tomlinson D editors. International Review of Neurobiology. Neurobiology of Diabetic Neuropathy. Vol. 50:New York: Academic Press; 2002;p. 230–255
  52. Schmidt RE, Dorsey DA, Beaudet LN, Parvin CA, Zhang W, Sima AF. Experimental rat models of type 1 and type 2 diabetes in sympathetic neuroaxonal dystrophy. Journal of Neuropathology and Experimental Neurology. 2004;63:450–460
  53. Starer P, Libow L. Cystometric evaluation of bladder dysfunction in elderly diabetic patients. Archives of Internal Medicine. 1990;150:810–813
  54. Steers WD, Mackway AM, Ciambotti J, DeGroat WC. Effects of streptozotocin-induced diabetes on bladder function in the rat. Journal of Urology. 1990;143:1032–1036
  55. Toyry JP, Partanen JV, Nishanen LK, Lansimies EA, Uusitupa MI. Divergent development of autonomic and peripheral somatic neuropathies in NIDDM. Diabetologia. 1997;40:953–958
  56. Ueda T, Tamaki M, Kageyama S, Yoshimura N, Yoshida O. Urinary incontinence among community-dwelling people aged 40 years or older in Japan: Prevalence, risk factors, knowledge and self-perception. International Journal of Urology. 2000;7:95–103
  57. Ueda T, Yoshimura N, Yoshida O. Diabetic cystopathy: Relationship to autonomic neuropathy detected by sympathetic skin response. Journal of Urology. 1997;157:580–584
  58. Vinik AI, Maser RE, Mitchell BD, Freeman R. Diabetic autonomic neuropathy. Diabetes Care. 2003;26:1553–1579
  59. Watanabe T, Miyagawa I. Effect of long-chain fatty alcohol on peripheral nerve conduction and bladder function in diabetic rats. Life Sciences. 2002;70:2215–2224
  60. Wetle T, Scherr P, Branch LG, Resnick NM, Harris T, Evans D, et al. Difficulty with holding urine among older persons in a geographically defined community: Prevalence and correlates. Journal of the American Geriatrics Society. 1995;43:349–455
  61. Woodman SE, Cheung MW, Tarr M, North AC, Schubert W, Lagaud G, et al. Urogenital alterations in aged male caveolin-1 knockout mice. Journal of Urology. 2004;171:950–957
  62. Yagihashi S, Sima AA. Neuroaxonal and dendritic dystrophy in diabetic autonomic neuropathy. Classification and topographic distribution in the BB-rat. Journal of Neuropathology and Experimental Neurology. 1986;45:545–565
  63. Yamazaki Y, Karakida T, Homma S. Conduction velocity of motor nerve and cervical sympathetic and vagus nerve in streptozotocin diabetic rats. Neuroscience Letters. 1990;113:29–33

☆ This work was supported by NIH grants 2R01 NS041194, 1P01 DK060037, and 2P60 DK20541-27.

PII: S1056-8727(05)00143-1

doi: 10.1016/j.jdiacomp.2005.10.001

Journal of Diabetes and Its Complications
Volume 21, Issue 3 , Pages 187-195 , May 2007

Article Tools

* Image Usage & Resolution